Cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: analysis by age group
Fecha de publicación
2015Título de revista
BJU INTERNATIONAL
Tipo de contenido
Publicación de congreso